Hankosky, PhD, senior director of Cardiometabolic Health, Health Economics and Outcomes Research at Eli Lilly & Company, and corresponding author of this study, confirmed for Medical News Today that the participants were taking Mounjaro as an off-label treatment for weight management at the discretion of their prescribing physician. During their study, researchers also reported that about 32% of participants who started tirzepatide had class 3 obesity with a BMI of 40 kg/m 2 or more
Mounjaro is typically more expensive than Wegovy, which can be a driving factor for many people who are seeking a cost-effective alternative
Lost 53 pounds
saw at least one improvement after their first check-in* 79% Hit your health goals with GLP-1 Injections Jumpstart your journey to a longer, healthier life
Who is this treatment not right for
Weekly injection scheduler (Ozempic/Wegovy) Pick one anchor: Sunday night after brushing teeth Monday morning after shower Friday after work (before weekend travel) Then add redundancy: Calendar event (recurring weekly) Phone alarm Keep supplies in one visible place Checkin points: Because Ozempic and Wegovy titrate in 4week steps on the FDA labels, set a recurring checkin every 4 weeks to review side effects and adherence (FDA Ozempic label, 2025